Acutaas Chemicals Limited (NSE:ACUTAAS)

Market Cap	98.50B
Revenue (ttm)	10.07B
Net Income (ttm)	1.59B
Shares Out	81.87M
EPS (ttm)	19.81
PE Ratio	60.74
Forward PE	43.91
Dividend	1.50 (0.12%)
Ex-Dividend Date	n/a

Volume	6,195
Average Volume	13,229
Open	1,208.00
Previous Close	1,207.90
Day's Range	1,187.70 - 1,230.00
52-Week Range	600.00 - 1,321.75
Beta	-0.09
RSI	63.11
Earnings Date	Jul 28, 2025

About Acutaas Chemicals

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formul...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2004
• Employees: 676
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ACUTAAS

Financial Performance

In 2024, Acutaas Chemicals's revenue was 10.07 billion, an increase of 40.34% compared to the previous year's 7.17 billion. Earnings were 1.59 billion, an increase of 271.06%.